Wilcox AJ, Weinberg CR, O'Connor JF, et al. Incidence of early loss of pregnancy. N. Engl. J. Med., 1988, 319: 189-94
Wilcox AJ, Baird DD, Weinberg CR. Time of implantation of the conceptus and loss of pregnancy. N. Engl. J. Med., 1999, 340: 1796-9
Bonduelle ML, Dodd R, Liebaers I, Van Steirteghem A, Williamson R, Akhurst R. Chorionic gonadotrophin-β mRNA, a trophoblast marker, is expressed in human 8-cell embryos derived from tripronucleate zygotes. Hum. Reprod., 1988, 3: 909-14
Lessey BA. Endometrial integrins and the establishment of uterine receptivity. Hum Reprod., 1998, 13 (suppl. 3): 247-58
Cullinan EB, Abbondanzo SJ, Anderson PS, Pollard JW, Lessey BA, Stewart CL. Leukemia inhibitory factor (LIF) and LIF receptor expression in human endometrium suggests a potential autocrine/paracrine function in regulating embryo implantation. Proc. Natl. Acad. Sci. USA, 1996, 93: 3115-20
Stewart CL, Kaspar P, Brunet LJ, Bhatt H, Gadi I, Kontgen F, Abbondanzo SJ. Blastocyst implantation depends on maternal expression of leukaemia inhibitory factor. Nature, 1992; 359: 76-9
Chaouat G, Menu E, Delage G, et al. Immuno-endocrine interactions in early pregnancy. Hum. Reprod., 1995, 10: 55-9
Perrier de Hauterive S, Hazee-Hagelstein MT, Van Cauwenberge JR et al. Paracrine control of cytokine (LIF, IL-6, and TNFa) production in cultures of human endometrial epithelium. Fertil. Steril., 1998, 70 (suppl. 1): O-166
Medawar PB. Some immunological and endocrinological problems raised by evolution of viviparity in vertebrates. Symp. Soc. Exp. Biol., 1953, 7: 320-28
Prabhala RII, Wira CR. Sex hormones and IL-6 regulation of antigen presentation in the female reproductive tract mucosal tissues. J. Immunol., 1995, 155: 5566-73
Le Bouteiller P, Rodriguez AM, Mallet V, Girt M, Guillaudeux T, Lenfant F. Placental expression of HLA class I genes. Am. J. Reprod. Immunol., 1996, 35: 216-25
Kovats S, Main EK, Librach C; Stubblebine M, Fisher SJ, De Mars R. A class I antigen, HLA-G, expressed in human trophoblasts. Science, 1990, 248: 220-3
Rouas-Freiss N, Goncalves RM, Menier C, Dausset J, Carosella ED. Direct evidence to support the role of HLA-G in protecting the fetus from maternal uterine natural killer cytolysis. Proc. Natl. Acad. Sci. USA, 1997, 94: 11520-25
Lanier L. NK cell receptors. Annu. Rev. Immunol., 1998, 16: 359-93
Fournel S, Aguerre-Girr M, Huc X et al. Soluble HLA-G1 triggers CD95/CD95 ligand-mediated apoptosis in activated CD8+ cells by interacting with CD8. J. Immunol., 2000, 164: 6100-4
Jurisicova A, Casper RF, MacLusky NJ, Mills GB, Librach CL. HLA-G expression during preimplantation human embryo development. Proc. Natl. Acad. Sci. USA, 1996, 93: 161-165
Le Bouteiller P, Solier C, Proll J, Aguerre-Girr M, Fournel S, Lenfant F. Placental HLA-G protein expression in vivo: wher and what for? Hum. Reprod. Update, 1999, 5: 223-33
Carosella ED, Paul P, Moreau P, Rouas-Freiss N. HLA-G and -E: fundamental and physiopathological aspects. Immunol. Today, 2000, 21: 2344-54
Moreau P, Adrian-Cabestre F, Menier C, et al. IL-10 selectively induces HLA-G expression in human trophoblasts and monocytes. Int. Immunol., 1999, 11: 803-11
Moreau P, Faure O, Lefebvre S, et al, Glucocorticoid hormones upregulate levels of HLA-G transcripts in trophoblasts. Transplant. Proc., 2001, 33: 2277-80
King A, Burrows T, Loke YW. Human uterine natural killer cells. Nat. Immunol., 1996, 15: 41-52
Guimond MJ, Luross JA, Wang B, Terhorst C, Danial S, Croy BA. Absence of natural killer cells during murine pregnancy is associated with reproductive compromise in Tge26 mice. Biol. Reprod., 1997, 56: 169-79
Ashkar AA, Di Santo JP, Croy BA. Interferon gamma contributes to initiation of uterine vascular modification, decidual integrity, and uterine natural killer cell maturation during normal murine pregnancy. J. Exp. Med., 2000, 192: 259-70
Guimond MJ, Wang B, Croy BA. Engraftment of bone marrow from severe combined immunodeficient (SCID) mice reverses the reproductive deficits in natural killer cell-deficient Tge26 mice. J. Exp. Med., 1998, 187: 217-23
Chantakru S, Miller C, Roach LE, Kuziel WA, Maeda N, Wang WC, Evans SS, Croy BA. Contributions from self-renewal and trafficking to the uterine NK cell population of early pregnancy. J. Immunol., 2002, 168: 22-28
Lin H, Mossmann TR, Guilbert L, Tuntipopipat S, Wegmann TG. Synthesis of T helper 2-type cytokines at the materno-fetal interface. J. Immunol., 1993, 151: 4562-73
Wegmann TG, Lin H, Guilbert L, Mossmann TR. Bidirectional cytokine interactions in the maternal-fetal relationship is successful pregnancy a TH2 phenomenon? Immunol. Today, 1993, 14: 353-56
Raghupathy R. Th1-type immunity is incompatible with successful pregnancy. Immunol. Today, 1997, 18: 478-82
Ashkar AA, Croy BA. Interferon-g contributes to the normalcy of murine pregnancy. Biol. Reprod., 1999, 61: 493-502
Svensson L, Arvola M, Sallstrom MA, Holmdahl R, Mattsson R. The Th2 cytokines IL-4 and IL-10 are not crucial for the completion of allogenic pregnancy in mice. J. Reprod. Immunol., 2001, 51: 3-7
Ohlsson R, Larsson E, Nilsson O, Wahlstrom T, Sundstrom P. Blastocyst implantation precedes induction of insulin-like growth factor-2 gene expression in human trophoblast. Development, 1989, 106: 555-9
Dokras A, Sargent IL, Ross C, Gardner RL, Barlow DH. The human blastocyst: morphology and human chorionic gonadotropin secretion in vitro. Hum. Reprod., 1991, 6: 1143-51
Khan-Dawood FS, Dawood MY. Chorionic gonadotropin receptors and immunoreactive chorionic gonadotropin in implantation of the arbbit blastocyst. Am. J. Obstet. Gynecol., 1984, 148: 359-65
Han SW, Lei ZM, Rao CV. Homologous down-regulation of luteinizing hormone/chorionic gonadotropin receptors by increasing the degradation of receptor transcripts in human uterine endometrial stromal cells. Biol. Reprod., 1997, 57: 158-64
Licht P, Russu V, Wildt L. On the role of human chorionic gonadotropin (hCG) in the embryo-endometrial microenvironment: implications for differentiation and implantation. Semin. Reprod. Med., 2001, 19: 37-47
Stewart EA, Sahakian M, Rhoades A, Van Voorhis BJ, Nowak RA. Messenger ribonucleic acid for the gonadal luteinizing hormone/human chorionic gonadotropin receptor is not present in human endometrium. Fert. Steril., 1999, 71: 368-72.
Zhou XL, Lei ZM, Rao CV. Treatment of human endometrial gland epithelial cells with chorionic gonadotropin/luteinizing hormone increases the expression of the cyclooxygenase-2 gene. J. Clin. Endocrinol. Metab., 1999, 84: 3364-77.
Matsuda JL, Kronenberg M. Presentation of self and microbial lipids by CD1 molecules. Curr. Opin. Immunol., 2001, 13: 19-25.
Ito K, Karasawa M, Kawano T, et al. Involvement of decidual Va14 NKT cells in abortion. Proc. Natl. Acad. Sci. USA, 2000, 97: 740-44.
Dang Y, Heyborne KD. Regulation of uterine NKT cells by a fetal class I molecule other than CD1. J. Immunol., 2001, 166: 3641-44.
Munn DH, Zhou M, Attwood JT, et al. Prevention of allogeneic fetal rejection by tryptophan catabolism. Science, 1998, 281: 1191-93.
Munn DH, Shafizadeh E, Attwood JT, Bondarev I, Pashine A, Mellor AL. Inhibition of T cell proliferation by macrophage tryptophan catabolism. J. Exp. Med., 1999, 189: 1363-72.
Xu C, Mao D, Holers VM, Palanca B, Cheng AM, Molina H. A critical role for murine complement regulator Crry in fetomaternal tolerance. Science, 2000, 287: 498-501.
Makrigiannakis A, Zoumakis E, Kalantaridou S, et al. Corticotropin-releasing hormone promotes blastocyst implantation and early maternal tolerance. Nat. Immunol., 2001, 2: 1018-24
Glinoer D. The regulation of thyroid function in pregnancy: pathways of endocrine adaptation from physiology to pathology. Endocr. Rev., 1997, 18: 404-33
Persellin H. The effect of pregnancy on rheumatoid arthritis. Bull. Rheum. Dis., 1976, 27: 922-27
Nelson JL, Hughes KA, Smith AG, Nisperos BB, Branchaud AM, Hansen JA. Maternal-fetal disparity in HLA class II alloantigens and the amelioration of rheumatoid arthritis. N. Engl. J. Med., 1993, 329: 466-71
Confavreux C, Hutchinson M, Hours MM, Cortinovis-Tourniaire P, Moreau T and the Pregnancy in Multiple Sclerosis Group. Rate of pregancy-related relapse in multiple sclerosis. N. Engl. J. Med., 1998, 339: 285-91
Abramsky O. Pregnancy and multiple sclerosis. Ann. Neurol., 1994, 36 (suppl.): S39-S41.
Gleicher N, Pratt D, Dudkiewicz A. What do we really know about autoantibody abnormalities and reproductive failure: a critical review. Autoimmunity, 1993, 16: 115-40
Reznikoff-Etievant MF, Cayol V, Zou GM, Abuaf N, Robert A, Johanet C, Milliez J. Habitual abortions in 678 healthy patients: investigation and prevention. Hum. Reprod., 1999, 14: 2106-9
Lockshin MD, Druzin ML, Goei S et al. Antibody to cardiolipin as a predictor of fetal distress or death in pregnant patients with systemic lupus erythematosous. N. Engl. J. Med., 1985, 313: 152-6
Rand JH, Wu XX, Andree HAM, Lockwood CJ, Guller S, Scher J, Harpel PC. Pregnancy loss in the antiphospholipid-antibody syndrome - a possible thrombogenic mechanism. N. Engl. J. Med., 1997, 337: 154-60
Angeles-Cano E, Sultan Y, Clauvel JP. Predisposing factors to thrombosis in systemic lupus erythematosous. Possible relation to endothelial cell damage. J. Lab. Clin. Med., 1979, 92: 313-23
Maejima M, Fujii T, Okai T, Kozuma S, Shibata Y, Taketani Y. β2-glycoprotein I-dpendent anticardiolipin antibody in early recurrent spontaneous abortion. Hum. Reprod., 1997, 12: 2140-42
Fisch B, Rikover Y, Shohat L, et al. The relationship between in vitro fertilization and naturally occurring antibodies; evidence for increased production of antiphospholipid antibodies. Fertil. Steril., 1991, 56: 718-24
Dmowski WP, Rana N, Michalowska J, Friberg J, Papierniak C, El-Roeiy. The effect of endometriosis, its stage and activity, and of autoantibodies on in vitro fertilization and embryo transfer success rates. Fertl. Steril., 1995, 63: 555-62
Sher G, Feinman M, Zouves C; Kuttner G, Maassarani G, et al. High fecundity rates following in-vitro fertilization and embryo transfer in antiphospholipid antibody seropositive women treated with heparin and aspirin. Hum. Reprod., 1994, 9: 2278-83
Laskin CA, Bombardier C, Hannah ME, et al. Prednisone and aspirin in women with autoantibodies and unexplaines recurrent fetal loss. N. Engl. J. Med., 1997, 337: 148-53
Hoek A, Schoemaker J, Drexhage HA. Premature ovarian failure and ovarian autoimmunity. Endocr. Rev., 1997, 18: 107-34
Elder M, Maclaren N, Riley W. Gonadal autoantibodies in patients with hypogonadism and/or Addison's disease. J. Clin. Endocrinol. Metab., 1981, 52: 1137-42
Glinoer D, Soto MF, Bourdoux P, et al. Pregnancy in patients with mild thyroid abnormalities: maternal and neonatal repercussions. J. Clin. Endocrinol. Metab., 1991, 73: 421-7
Stagnaro-Green A, Roman SH, Cohen RH, El-Harazy E, Alvarez-Marfani M, Davies TF. Detection of at-risk pregnancy by means of highly sensitive assays for thyroid antibodies. J. Am. Med. Assoc., 1990, 264: 1422-25
Pratt DE, Kaberlein G, Dudkiewicz A, Karande V, Gleicher N. The association of antithyroid antibodies in euthyroid nonpregnant women with recurrent first trimester abortions in the next pregnancy. Fertil. Steril., 1993, 60: 1001-5
Bagis T, Gokcel A, Saygili ES. Autoimmune thyroid disease in pregnancy and the postpartum period: relationship to spontaneous abortion. Thyroid, 2001, 11: 1049-53
Haddow JE, Palomaki GE, Allan WC, et al. Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child. N. Engl. J. Med., 1999, 341: 549-55
